Primary non-adherent (%) | Secondary non-adherent (%) | Adherent (%) | P-value (χ 2 Pearson’s) | |
---|---|---|---|---|
Tumor stage | ||||
T1 | 83 (82.2) | 95 (50.5) | 508 (56.3) | < 0.001 |
T2 | 14 (13.9) | 67 (35.6) | 275 (30.5) | |
T3-T4 | 2 (2.0) | 2 (1.1) | 28 (3.1) | |
Unknown | 2 (2.0) | 24 (12.8) | 92 (10.2) | |
Histological grade | ||||
Grade 1 | 3 (3.0) | 25 (13.3) | 76 (8.4) | < 0.001 |
Grade 2 | 87 (86.1) | 92 (48.9) | 507 (56.1) | |
Grade 3 | 10 (9.9) | 46 (24.5) | 229 (25.4) | |
Unknown | 1 (1.0) | 25 (13.3) | 91 (10.1) | |
Axillary lymph node metastasis | ||||
0 | 90 (89.1) | 102 (54.3) | 473 (52.4) | < 0.001 |
1-3 | 7 (6.9) | 47 (25.0) | 280 (31.0) | |
≥ 4 | 1 (1.0) | 23 (12.2) | 119 (13.2) | |
Unknown | 3 (3.0) | 16 (8.5) | 31 (3.4) | |
Radiation | ||||
No | 39 (38.6) | 72 (38.3) | 234 (25.9) | < 0.001 |
Yes | 62 (61.4) | 116 (61.7) | 669 (74.1) | |
Chemotherapy | ||||
No | 96 (95.0) | 101 (53.7) | 379 (42.0) | < 0.001 |
Yes | 5 (5.0) | 87 (46.3) | 524 (58.0) | |
Neoadjuvant treatment | ||||
No | 99 (98.0) | 154 (81.9) | 764 (84.6) | < 0.001 |
Yes | 2 (2.0) | 34 (18.1) | 139 (15.4) |